Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man

REFERENCES

• Andrews, P. (1976). Pharmacokinetic studies with praziquantel in animals using a biological assay. Veterinärmedizinische Nachrichten, 2, 154–165.
   Google Scholar
• Apajalahti, J. (1977). Treatment of Diphyllobothrium latum infections with a single oral dose of praziquantel. Boletín Chileno de Parasitología, 32, 43.
   PubMedGoogle Scholar
• Baranski, M. C. (1977). Treatment of human taeniasis and hymenolepiasis with praziquantel (Embay 8440). Boletín Chileno de Parasitologia, 32, 37–39.
   PubMedGoogle Scholar
• Bartsch, H., Kuroki, T., Malaveille, C., Loprieno, N., Barale, R., Abbondandolo, A., Bonatti, S., Rainaldi, G., Vogel, E. & Davis, A. (1978). Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal drug, in bacteria, yeasts, insects and mammalian cells. Mutation Research, 58, 133–142.
   PubMed Web of Science ®Google Scholar
• Bühring, K. U., Diekmann, H. W., Garbe, A. & Nowak, H. (1978). Metabolism of praziquantel in man. European Journal of Drug Metabolism and Pharmacokinetics, 3, 179–190.
   Google Scholar
• Bylund, G., Bang, B. & Wikgren, K. (1977). Test with a new compound (Praziquantel) against Diphyllobothrium latum. Journal of Helminthology, 51, 115–119.
   PubMed Web of Science ®Google Scholar
• Canzonieri, C. J., Rodriguez, E. R., Castillo, R. E., de Balella, C. I. & Lucena, M. (1977). Therapeutic trial with praziquantel in Taenia saginata and Hymenolepis nana infections. Boletín Chileno de Parasitología, 32, 41–42.
   PubMedGoogle Scholar
• Cho, K. M., Kim, C. H., Ahn, Y. K. & Soh, C. T. (1966a). Experimental studies of 1,4-bis-trichloromethyl-benzol on the infection of Clonorchis sinensis. Korean Journal of Parasitology, 4, 11–20.
   Google Scholar
• Cho, M. J., Cho, K. M. & Soh, C. T. (1966b). The use of Hetol on the infection of Chlonorchis sinensis. Korean Journal of Parasitology, 4, 21–31.
   Google Scholar
• Chung, H. L., Hsü, C. P., Ts'Ao, W. C., K'o, H. Y., Kuo, C. H., HsÜ, H. C., Li, P. S., Cheng, S., Chang, H. Y., Yuan, G. T. & Chang, Y. C. (1975). Hexachloroparaxylol in treatment of Clonorchiasis sinensis in animals and man. Chinese Medical Journal, 84, 232–247.
   Google Scholar
• Davis, A., Biles, I. E. & Ulrich, A. M. (1979). Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium. Bulletin of the World Health Organization, 57, 773–779.
   PubMed Web of Science ®Google Scholar
• Diekmann, H. W. & BÜhring, K. U. (1976). The fate of praziquantel in the organism. III. Metabolism in rat, beagle dog and rhesus monkey. European Journal of Drug Metabolism and Pharmacokinetics, 1, 107–112.
   Google Scholar
• Drozdov, V. N. (1965). First experience using hexachloroparaxylol (Chloxyle) for treatment of opisthorchiasis in children. Meditsinskaia parazitologiia i parazitarnye bolezni (Moskva), 34, 424–426.
   Google Scholar
• Espejo, H. (1977). Treatment of infections by Hymenolepis nana, Taenia saginata, Taenia solium and Diphyllobothrium pacificum with praziquantel (Embay 8440). Boletín Chileno de Parasitología, 32, 39–40.
   PubMedGoogle Scholar
• Gönnert, R. & Andrews, P. (1977). Praziquantel, a new broad spectrum antischistosomal agent. Zeitschrift für Parasitenkunde, 52, 129–150.
   PubMed Web of Science ®Google Scholar
• Harinasuta, C., Bunnag, D., Wiriyawit, P. & Petchklah, S. (1966). The treatment of Opisthorchiasis viverrini with 1,4-bis-trichloromethylbenzol (Hetol). Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 690.
   Web of Science ®Google Scholar
• James, C., Webbe, G. & Nelson, G. S. (1977). The susceptibility to praziquantel of Schistosoma haematobium in the baboon and of S. japonicum in the vervet monkey. Zeitschrift für Parasitenkunde, 52, 179–194.
   PubMed Web of Science ®Google Scholar
• Katz, N., Rocha, R. S. & Chaves, A. (1979). Preliminary trials with praziquantel in human infections due to Schistosoma mansoni. Bulletin of the World Health Organization, 57, 781–785.
   PubMed Web of Science ®Google Scholar
• Leopold, G., Groll, E., Diekmann, H. W., Nowak, H. & Wegner, D. H. G. (1978). Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics. European Journal of Clinical Pharmacology, 14, 281–291.
   PubMed Web of Science ®Google Scholar
• Machemer, L. & Lorke, D. (1978). Mutagenicity studies with praziquantel, a new anthelmintic drug, in mammalian systems. Archives of Toxicology, 39, 187–197.
   PubMed Web of Science ®Google Scholar
• MÜrmann, P., Eberstein, Mv. & Frohberg, H. (1976). Zur Verträglichkeit von Praziquantel. Veterinärmedizinische Nachrichten, 2, 142–153.
   Google Scholar
• Obermeier, J. & Frohberg, H. (1977). Mutagenicity studies with praziquantel, a new anthelmintic drug: tissue-, host-, and urine-mediated mutagenicity assays. Archives of Toxicology, 38, 149–161.
   PubMed Web of Science ®Google Scholar
• Paz, G. (1977). Treatment of Taeniasis saginata with praziquantel (Embay 8440). Boletín Chileno de Parasitología, 32, 14–16.
   PubMedGoogle Scholar
• Pellegrino, J., Lima-Costa, F. F., Carlos, M. A. & Mello, R. T. (1977). Experimental chemotherapy of schistosomiasis mansoni. XIII. Activity of praziquantel, an isoquinoline-pyrazino-derivate, on mice, hamsters and Cebus monkeys. Zeitschrift für Parasitenkunde, 52, 152–168.
   Web of Science ®Google Scholar
• Plotnikov, N. N., Ozeretskovskaya, N. N., Krylova, A. S., Alekseeva, M. L. & Tumolskaya, N. I. (1969). Comparative effectiveness of treatment of human opisthorchiasis with hexachloroparaxylol (Chloxyle) by different methods of its administration. Meditsinskaia parazitologiia i parazitarnye bolezni (Moskva) 38, 537–539.
   PubMedGoogle Scholar
• Rim, H.J. (1972). Chemotherapy on trematode infections excluding schistosomiasis. Proceedings 10th SEAMEO-Seminar on Tropical Medicine, Bangkok, (1971), 67–76.
   Google Scholar
• Rim, H. J. (1974). Treatment of paragonimiasis with niclofolan (Bayer, 9015, Bilevon). Proceedings of the Third International Congress of Parasitology, Munich, 3, 13333.
   Google Scholar
• Rim, H.J. & Lee, S. I. (1978). Chemotherapeutic effect of niclofolan (Bayer, 9015, Bilevon) in the treatment of Clonorchiasis. Korea University Medical Journal, 16, 167–182.
   Google Scholar
• Rim, H.J. & Lyu, K. S. (1979a). Chemotherapeutic effect of praziquantel (Embay 8440) in the treatment of chlonorchiasis sinensis. Korea University Medical Journal, 16, 459–470.
   Google Scholar
• Rim, H. J., Park, C. Y., Lee, J. S., Joo, K. H. & Lyu, K. S. (1978a). Therapeutic effects of praziquantel (Embay 8440) against Hymenolepis nana infection. Korean Journal of Parasitology, 16, 82–87.
   Google Scholar
• Rim, H. J., Chu, D. S., Lee, J. S., Joo, K. H. & Won, C. Y. (1978b). Anthelmintic effects of various drugs against metagonimiasis. Korean Journal of Parasitology, 16, 117–122.
   Google Scholar
• Rim, H. J., Park, S. B., Lee, J. S. & Joo, K. H. (1979b). Therapeutic effects of praziquantel (Embay 8440) against Taenia solium infection. Korean Journal of Parasitology, 17, 67–72.
   Google Scholar
• Santos, A. T., Blas, B. L., Nosenas, I. S., Portillo, G. P., Ortega, O. M., Hayashi, M. & Boehme, K. (1979). Preliminary clinical trials with praziquantel in S. japonicum infection in the Philippines. Bulletin of the World Health Organization, 57, 793–799.
   PubMed Web of Science ®Google Scholar
• Schenone, H., Galdames, M., Rivadeneira, A., Morales, E., Hoffman, M. T., Asalgado, H., Meneses, G., Mora, M. V. & Cabrera, G. (1977). Treatment of Hymenolepis nana infection in children by a single oral dose of praziquantel (Embay 8440). Boletín Chileno de Parasitología, 32, 11–13.
   PubMedGoogle Scholar
• Steiner, K., Garbe, A., Diekmann, H. W. & Nowak, H. (1976). The fate of praziquantel in the organism. I. Pharmacokinetics in animals. European Journal of Drug Metabolism and Pharmacokinetics, 1, 85–95.
   Google Scholar
• Steiner, K. & Garbe, A. (1976). The fate of praziquantel in the organism. II. Distribution in rats. European Journal of Drug Metabolism and Pharmacokinetics, 1, 97–106.
   Google Scholar
• Thomas, H., Gönnert, H., Pohlke, R. & Seubert, J. (1975). Investigations about treatment of larval tissue stages with a new compound. Proceedings of the 7th International Conference of Pathophysiology of Parasitic Infections, Thessaloniki, 49.
   Google Scholar
• Thomas, H. & Gönnert, R. (1977a). The efficacy of praziquantel against cestodes in animals. Zeitschrift für Parasitenkunde, 52, 117–127.
   PubMed Web of Science ®Google Scholar
• Thomas, H. (1977b). Experimental results with Embay 8440 in cestodiasis and cysticercosis. Boletín Chileno de Parasitología, 32, 2–6.
   PubMedGoogle Scholar
• Thomas, H. & Gönnert, R. (1978a). The efficacy of praziquantel against cestodes in cats, dogs and sheep. Research in Veterinary Science, 24, 20–25.
   PubMed Web of Science ®Google Scholar
• Thomas, H. & Gönnert, R. (1978b). Zur Wirksamkeit von Praziquantel bei der experimentellen Cysticercose und Hydatidose. Zeitschrift für Parasitenkunde, 55, 165–179.
   PubMed Web of Science ®Google Scholar
• Webbe, G. & James, C. (1977) 1 A comparison of the susceptibility of praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and mattheei in hamsters. Zeitschrift für Parasitenkunde, 52, 169–177.
   PubMed Web of Science ®Google Scholar